UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis

Arthritis research & therapy, 2015-01, Vol.17 (1), p.7-7

2015

Volltextzugriff (PDF)

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension

Arthritis research & therapy, 2017-06, Vol.19 (1), p.122-122, Article 122

2017

Volltextzugriff (PDF)

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3

Arthritis research & therapy, 2014-10, Vol.16 (5), p.438-438, Article 438

2014

Volltextzugriff (PDF)

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

Arthritis research & therapy, 2012-06, Vol.14 (3), p.R143-R143

2012

Volltextzugriff (PDF)

Seronegative spondyloarthritis

Best practice & research. Clinical rheumatology, 2010-12, Vol.24 (6), p.747-756

2010

Volltextzugriff (PDF)

Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes

Journal of rheumatology, 2005-07, Vol.32 (7), p.1290

2005

Volltextzugriff (PDF)

Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health

Journal of rheumatology, 2006-12, Vol.33 (12), p.2475

2006

Volltextzugriff (PDF)

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.123

2020

Volltextzugriff (PDF)

Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life

Rheumatology (Oxford, England), 2018-01, Vol.57 (1), p.73-83

2018

Volltextzugriff (PDF)

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

Arthritis research & therapy, 2017-03, Vol.19 (1), p.42-42, Article 42

2017

Volltextzugriff (PDF)

A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis

Journal of rheumatology, 2007-01, Vol.34 (1), p.64

2007

Volltextzugriff (PDF)

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

Rheumatology (Oxford, England), 2013-01, Vol.52 (1), p.155-160

2013

Volltextzugriff (PDF)

Barriers to Optimal Disease Control for Rheumatoid Arthritis Patients With Moderate and High Disease Activity

Arthritis care & research (2010), 2014-02, Vol.66 (2), p.190-196

2014

Volltextzugriff (PDF)

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Annals of the rheumatic diseases, 2018-05, Vol.77 (5), p.690

2018

Volltextzugriff (PDF)

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease

Clinical and experimental rheumatology, 2015-07, Vol.33 (4 Suppl 91), p.S111

2015

Volltextzugriff (PDF)

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study

Clinical and experimental rheumatology, 2016-09, Vol.34 Suppl 100 (5), p.170

2016

Volltextzugriff (PDF)

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

Scientific reports, 2019-10, Vol.9 (1), p.14834-5, Article 14834

2019

Volltextzugriff (PDF)

The role of inflammatory markers in assessment of disease activity in systemic sclerosis

Clinical and experimental rheumatology, 2018-07, Vol.36 Suppl 113 (4), p.126

2018

Volltextzugriff (PDF)

The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis

Journal of rheumatology, 2013-03, Vol.40 (3), p.228

2013

Volltextzugriff (PDF)

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

Arthritis research & therapy, 2016-10, Vol.18 (1), p.246-246, Article 246

2016

Volltextzugriff (PDF)

Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study

Journal of rheumatology, 2015-09, Vol.42 (9), p.1603

2015

Volltextzugriff (PDF)

Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis

Clinical and experimental rheumatology, 2017-09, Vol.35 Suppl 106 (4), p.130

2017

Volltextzugriff (PDF)

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study

Arthritis research & therapy, 2013-01, Vol.15 (6), p.R193-R193

2013

Volltextzugriff (PDF)

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study

Clinical and experimental rheumatology, 2016-09, Vol.34 Suppl 100 (5), p.129

2016

Volltextzugriff (PDF)

Magnetic resonance imaging in ankylosing spondylitis

Current opinion in rheumatology, 2007-07, Vol.19 (4), p.346-352

2007

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(38)
Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Male
(36)
Rheumatology
(34)
Middle Aged
(30)
Aged
(25)
Adult
(16)
Severity Of Illness Index
(12)
Treatment Outcome
(12)
Australia
(11)
Systemic Sclerosis
(10)
Cross-Sectional Studies
(9)
Rheumatoid Arthritis
(9)
Scleroderma
(9)
Aged, 80 And Over
(8)
Ankylosing Spondylitis
(8)
Cohort Studies
(8)
Scleroderma, Systemic - Complications
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study

Seronegative spondyloarthritis

Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes

Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

A comparative study of patient-reported functional outcomes in acute rheumatoid arthritis

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

Barriers to Optimal Disease Control for Rheumatoid Arthritis Patients With Moderate and High Disease Activity

Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)

Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease

Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study

IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis

The role of inflammatory markers in assessment of disease activity in systemic sclerosis

The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis

The association of low complement with disease activity in systemic sclerosis: a prospective cohort study

Patients with Rheumatoid Arthritis in the Australian OPAL Cohort Show Significant Improvement in Disease Activity over 5 Years: A Multicenter Observational Study

Validity of the Workers Productivity and Activity Impairment Questionnaire: Specific Health Problem (WPAI:SHP) in patients with systemic sclerosis

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study

The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study

Magnetic resonance imaging in ankylosing spondylitis

Aktive Filter

Suchergebnisse filtern